This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
L'Oreal SA (LRLCY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
L'Oreal SA (LRLCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Buy These "Beauty" Stocks for More Gains?
by Shaun Pruitt
Hopes of a less hawkish FED could boost the Consumers Staples sector with several stocks among the Zacks Cosmetic Industry standing out in particular.
International Flavors (IFF) Encapsulates Vegan Supplements
by Zacks Equity Research
International Flavors (IFF) creates a technological breakthrough with its leading patented SeaGel technology.
An Update on the Q4 Earnings Season
by John Blank
It's time for the latest perspective, coming from the data.
Here's Why L'Oreal SA (LRLCY) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does L'Oreal SA (LRLCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Big Tech Reports: Global Week Ahead
by John Blank
Microsoft (MSFT), the second biggest U.S. company by market value, reports on Tuesday, followed by Elon Musk's Tesla (TSLA) on Wednesday. That's just the warm up for next week.
Big Tech Reports: Global Week Ahead
by John Blank
Microsoft (MSFT), the second biggest U.S. company by market value, reports on Tuesday, followed by Elon Musk's Tesla (TSLA) on Wednesday. That's just the warm up for next week.
Portfolio Makeover: 3 Cosmetics Leaders to Watch
by Andrew Rocco
Elf Beauty, Inter Parfums and L'Oreal are leaders in the highly -rated Cosmetics industry.
L'Oreal SA (LRLCY) Upgraded to Buy: Here's Why
by Zacks Equity Research
L'Oreal SA (LRLCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LOreal SA (LRLCY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
LOreal SA (LRLCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HELE vs. LRLCY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HELE vs. LRLCY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: General Mills, McCormick, Nestle, L'Oreal and J.M. Smucker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Mills, McCormick, Nestle, L'Oreal and J.M. Smucker
4 Food Stocks to Eat Up Heading into Q2 Earnings Season
by Zachary Stutler
Here are a few companies in the consumer staple industry, which is typically less volatile relative to other industries, that have the potential to outperform their peers.
The Zacks Analyst Blog Highlights: L'Or??al, Kering, TOTAL, Deutsche Telekom and Davide
by Zacks Equity Research
The Zacks Analyst Blog Highlights: L'Or??al, Kering, TOTAL, Deutsche Telekom and Davide
5 Stocks to Buy on European Parliament Election Results
by Tirthankar Chakraborty
European stocks get a lift after EU parliamentary election results show more support for pro-EU, business-friendly centrists.
Estee Lauder (EL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Two Powerhouse CEOs are Now on Glossier's Board of Directors
by Nimah Quadri
Recently, Katrina Lake, the CEO of Stich Fix (SFIX), joined the board of growing beauty products company Glossier as their first independent director. This new addition to the team is a big one for the company, seeing as Lake's success is valued by many.
Will Coty Benefit from Calvin Klein's Celebrity Endorsement?
by Zacks Equity Research
Coty's (COTY) Luxury segment revenues to benefit from the new ETERNITY Calvin Klein campaign. The same is expected to raise marketing spending.
Google's Rating Cut Over YouTube Ad Placements
by Joseph Lu
Alphabet Inc. (GOOGL), the parent company of Google, received a downgrade today to "Hold" from "Buy" by Pivotal Research analyst Brian Wieser. The reason for the rating cut centered on the placement of YouTube???s ads. Some ad buyers had voiced that their ads appeared next to videos carrying homophobic or terroristic videos on YouTube.
Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement
by Parth Panchal
Pharmaceutical and biotech company Valeant Pharma (VRX) slipped down 4.33% to $12.50 intraday Monday due to an announcement of debt restructuring.
What Makes Avon Products (AVP) a Strong Sell?
by Zacks Equity Research
Avon Products (AVP), has witnessed a significant price decline and negative trend in earnings estimate revisions